Precure Targeted Accrual and Rapid Growth in Enrollment Trial Study
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07756320
- Status
- Enrolling By Invitation
Conditions
- Exposure, Environmental
- Genetic Predisposition
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy. Participants will be asked to: * collect biological samples
Key Dates
- First listed
- Aug 10, 2026
- Start date
- Aug 7, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2035
Study Design
- Enrollment
- 100,000 participants (estimated)
Primary Outcome Measure
Build a comprehensive, multi-omics and phenotype data and biorepository. [ Time Frame: Up to 5 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site
Related Studies
- Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific DiscoveryEnrolling By Invitation · Mayo Clinic · Scottsdale, Arizona
- The Effect of rs7903146 Genotype on Islet GLP-1 Production in HumansPHASE2 · Not Yet Recruiting · Mayo Clinic · Rochester, Minnesota
- Mayo Clinic Precure - Prospective StudyEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Vascular Disease Discovery ProtocolRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland